NovaBay Pharmaceuticals to Participate in Virtual 33rd Annual Roth Conference

Rhea-AI Summary

NovaBay Pharmaceuticals (NYSE American: NBY) will hold one-on-one investor meetings at the Virtual 33rd Annual Roth Conference from March 15-17, 2021. The company focuses on commercializing Avenova® for eye care and CelleRx® Clinical Reset™ for beauty. Investors can arrange meetings through Roth Capital Partners or LHA Investor Relations. Additionally, the corporate presentation is available on the company's website. NovaBay specializes in non-antibiotic anti-infective products, including the NEUTROX® family and AGANOCIDE® compounds.

NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova^® for the eye care market and CelleRx^® Clinical Reset™ for the beauty market, announces that management will hold one-on-one investor meetings at the Virtual 33^rd Annual Roth Conference being held March 15-17, 2021.

Investors interested in arranging a meeting with NovaBay management should contact their Roth Capital Partners sales representative or LHA Investor Relations. The NovaBay corporate presentation can be access from the Investors section of the Company’s website here. Roth Conference information is available here.

About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics^®

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX^® family of products and the AGANOCIDE^® compounds. The Neutrox family of products includes AVENOVA^® for the eye care market, NEUTROPHASE^® for wound care market, and CELLERX^® for the aesthetic dermatology market. The Aganocide compounds, still under development, have target applications in the dermatology and urology markets.

Socialize and Stay informed on NovaBay’s progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

CelleRx Clinical Reset Purchasing Information
For NovaBay CelleRx Clinical Reset purchasing information
Please call 877-CELLERX
www.CelleRx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005092/en/

FAQ

When is NovaBay Pharmaceuticals participating in the Roth Conference in 2021?

NovaBay Pharmaceuticals will be at the Virtual 33rd Annual Roth Conference from March 15-17, 2021.

How can investors meet with NovaBay management during the Roth Conference?

Investors can arrange meetings with NovaBay management through Roth Capital Partners or LHA Investor Relations.

What products does NovaBay Pharmaceuticals focus on?

NovaBay focuses on Avenova® for eye care and CelleRx® Clinical Reset™ for the beauty market.

Where can I find NovaBay's corporate presentation?

NovaBay's corporate presentation can be accessed from the Investors section of their website.

What is the stock symbol for NovaBay Pharmaceuticals?

The stock symbol for NovaBay Pharmaceuticals is NBY.